Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Osteoprotegerin expression correlates with ER/PR status in human breast tumors
    Meeting Abstract

    Van Poznak, C. H.; Cross, S. S.; Hudis, C.; Panageas, K. S.; Coleman, R. E.; Holen, I.
    Journal of Bone and Mineral Research (2003)

    Fulltext@MSK | Save
  • Osteoprotegerin (OPG) and tumor necrosis factor-related apoptosis inducing ligand (TRAIL) are expressed in human breast tumors
    Meeting Abstract

    Van Poznak, C. H.; Cross, S. S.; Hudis, C.; Norton, L.; Panageas, K. S.; Coleman, R. E.; Holen, I.
    Breast Cancer Research and Treatment (2003)

    Fulltext@MSK | Save
  • Concordance of estrogen and progesterone receptor status, and Her-2/neu protein expression in paired primary breast carcinomas and lymph node metastases
    Meeting Abstract

    Torres-Matundan, E.; Brogi, E.; Tracey, J.; Norton, L.; Hudis, C.; Robson, M.; Tan, L. K.
    Modern Pathology (2003)

    Fulltext@MSK | Save
  • Concordance of estrogen and progesterone receptor status, and Her-2/neu protein expression in paired primary breast carcinomas and lymph node metastases
    Meeting Abstract

    Torres-Matundan, E.; Brogi, E.; Tracey, J.; Norton, L.; Hudis, C.; Robson, M.; Tan, L. K.
    Laboratory Investigation (2003)

    Fulltext@MSK | Save
  • Pulsatile administration of the EGF receptor inhibitor gefitinib (Iressa, ZD 1839) is significantly more effective than continuous dosing for sensitizing tumors to Taxol
    Meeting Abstract

    Solit, D. B.; She, Y.; Moasser, M.; Hudis, C.; Kris, M.; Scher, H.; Rosen, N.; Sirotnak, F. M.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Rapid MicroPET imaging of 17AAG induced HER2 protein downregulation using Ga-68-DOTA-F(ab ')(2) herceptin
    Meeting Abstract

    Smith-Jones, P. M.; Solit, D.; Afroze, F.; Akhurst, T.; Rosen, N.; Larson, S. M.
    Journal of Nuclear Medicine (2003)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras
    Meeting Abstract

    Sawai, A.; Basso, A. D.; Solit, D. B.; She, Q. B.; Grbovic, O.; Pratilas, C.; Chapman, P.; Moasser, M. M.; Rosen, N.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Development of a fluorescence polarization assay for the molecular chaperone Hsp90
    Meeting Abstract

    Llauger, L.; He, H.; Kim, J.; Rosen, N.; Chiosis, G.
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Determinants of response to gefitinib (Iressa®, ZD1839) in patients with advanced breast cancer
    Meeting Abstract

    Iacobuzio-Donahue, C. A.; Albain, K.; Elledge, R.; Gradishar, W.; Hayes, D.; Rowinsky, E.; Hudis, C.; Pusztai, L.; Tripathy, D.; Modi, S.; more...
    Clinical Cancer Research (2003)

    Fulltext@MSK | Save
  • Early treatment of mild anemia with once-weekly epoetin alfa significantly improves hemoglobin and quality of life in early-stage breast cancer patients during conventional adjuvant chemotherapy
    Meeting Abstract

    Hudis, C. A.; Williams, D.
    Breast Cancer Research and Treatment (2003)

    Fulltext@MSK | Save